These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
394 related items for PubMed ID: 25501933
1. Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study. Dallmeier D, Denkinger M, Peter R, Rapp K, Jaffe AS, Koenig W, Rothenbacher D, ActiFE Study Group. Clin Chem; 2015 Feb; 61(2):389-99. PubMed ID: 25501933 [Abstract] [Full Text] [Related]
2. A prospective assessment of cardiac biomarkers for hemodynamic stress and necrosis and the risk of falls among older people: the ActiFE study. Dallmeier D, Klenk J, Peter RS, Denkinger M, Peter R, Rapp K, Koenig W, Rothenbacher D. Eur J Epidemiol; 2016 Apr; 31(4):427-35. PubMed ID: 26130126 [Abstract] [Full Text] [Related]
3. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Apple FS, Murakami MM, Pearce LA, Herzog CA. Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888 [Abstract] [Full Text] [Related]
4. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study. Kim Y, Matsushita K, Sang Y, Grams ME, Skali H, Shah AM, Hoogeveen RC, Solomon SD, Ballantyne CM, Coresh J. Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023 [Abstract] [Full Text] [Related]
5. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A. Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860 [Abstract] [Full Text] [Related]
6. Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients. Chen JR, Wang Q, Wu W, Zhang SJ. Clin Interv Aging; 2019 May; 14():81-90. PubMed ID: 30643397 [Abstract] [Full Text] [Related]
7. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study. Voroneanu L, Siriopol D, Nistor I, Apetrii M, Hogas S, Onofriescu M, Covic A. Kidney Blood Press Res; 2014 May; 39(6):636-47. PubMed ID: 25571877 [Abstract] [Full Text] [Related]
8. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Tsutamoto T, Kawahara C, Nishiyama K, Yamaji M, Fujii M, Yamamoto T, Horie M. Am Heart J; 2010 Jan; 159(1):63-7. PubMed ID: 20102868 [Abstract] [Full Text] [Related]
9. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements. Alehagen U, Dahlström U, Rehfeld JF, Goetze JP. Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063 [Abstract] [Full Text] [Related]
10. Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study. Juraschek SP, Daya N, Appel LJ, Miller ER, Matsushita K, Michos ED, Windham BG, Ballantyne CM, Selvin E. J Am Geriatr Soc; 2019 Sep; 67(9):1795-1802. PubMed ID: 31493355 [Abstract] [Full Text] [Related]
12. Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial. Røsjø H, Hijazi Z, Omland T, Westerbergh J, Lyngbakken MN, Alexander JH, Gersh BJ, Granger CB, Hylek EM, Lopes RD, Siegbahn A, Wallentin L. J Intern Med; 2020 Aug; 288(2):248-259. PubMed ID: 32350915 [Abstract] [Full Text] [Related]
13. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study. Berge K, Lyngbakken MN, Myhre PL, Brynildsen J, Røysland R, Strand H, Christensen G, Høiseth AD, Omland T, Røsjø H. Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872 [Abstract] [Full Text] [Related]
14. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis. Gravning J, Smedsrud MK, Omland T, Eek C, Skulstad H, Aaberge L, Bendz B, Kjekshus J, Mørkrid L, Edvardsen T. Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908 [Abstract] [Full Text] [Related]
15. Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: The North South East West Trial. Gaggin HK, Dang PV, Do LD, deFilippi CR, Christenson RH, Lewandrowski EL, Lewandrowski KB, Truong BQ, Pham VQ, Vu VH, Vu TV, Nguyen TB, Belcher AM, Femia A, Kelley C, Januzzi JL. Clin Chem; 2014 May; 60(5):758-64. PubMed ID: 24568795 [Abstract] [Full Text] [Related]
16. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes. Costacou T, Saenger AK, Orchard TJ. Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616 [Abstract] [Full Text] [Related]
17. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study. Ishigami J, Hoogeveen RC, Ballantyne CM, Folsom AR, Coresh J, Selvin E, Matsushita K. Am J Epidemiol; 2019 Dec 31; 188(12):2146-2155. PubMed ID: 31063194 [Abstract] [Full Text] [Related]